Jung’s pending hand decision puts a productive Rangers bat in focus

Josh Jung’s offseason is beginning without a treatment answer. At Monday afternoon’s end-of-season news conference, Texas baseball executive Chris Young said both surgical and nonsurgical paths remain under consideration for Jung’s fractured right hand. The injury occurred when Jung was hit by a Joe Ryan pitch Friday, but no procedure has been scheduled and no final choice has been announced.

Jung hit .299/.365/.462 over 104 appearances this season. That makes the unresolved treatment decision a baseball concern as well as a medical one. Texas has a productive hitter to plan around and uncertainty about the next step. The club should keep the quality of his contribution in view while addressing the interruption.

The medical decision is unresolved. The offensive evidence is not.

Production worth preserving

Jung’s line had more substance than a home-run total might suggest. His 27 doubles accounted for a sizable portion of his 119 hits, and his 35 walks helped push his on-base percentage to .365. In 444 plate appearances, he accumulated 184 total bases and struck out 80 times.

That is a useful blend of contact, extra-base ability and inning extension, even without pretending the rates were guaranteed to hold over a full schedule.

A 104-game sample is substantial enough to take seriously without projecting the same rates across every remaining date. Jung gave Texas reasons to keep investing in his contribution: getting on base, supplying extra-base hits and extending the possibilities within an inning. A club does not have to predict an identical season to recognize that replacing such work could be difficult.

The hand fracture followed a separate interruption earlier in the year. A calf problem kept Jung out for 47 games, according to the Dallas Morning News. Texas therefore has more than one availability issue to consider, while keeping the two events distinct. The earlier absence and the pitch that struck his hand should not be folded into a convenient single explanation.

Young identified health, reliability and dependability as offseason priorities. He described reviewing individual offseason programs, monitoring them when possible, using outside doctors and therapists, and tailoring assessments. He also declined to blame the training staff, pointing to its work in keeping Jacob deGrom available. That leaves the Rangers with a review process rather than a declared culprit, staffing change or sweeping overhaul.

The two decisions run alongside each other. Treatment belongs with the player and his medical advisers. Roster planning belongs with baseball operations, which needs to prepare for uncertainty without downgrading a player’s demonstrated value merely because a timetable remains open.

A hitter’s value survives an interrupted schedule

Corey Seager supplies a useful comparison within the same club. He appeared in 102 games and finished with a .736 OPS, while Jung reached .827 in 104 appearances. Similar game totals did not produce identical offensive seasons. Each player’s contribution requires its own evaluation, just as their pending treatment decisions concern different physical problems.

That is why a broad campaign for dependability can only take the assessment so far. Texas should want more appearances from its important hitters, but it also needs to preserve and develop what makes those appearances valuable. Jung’s doubles, walks and overall batting line supply a clear reason to keep him central to that effort.

The target is useful participation, rather than attendance considered in isolation.

A workable plan would preserve a place for Jung’s bat and include credible cover when he cannot supply it. That approach respects the player Texas had in those 104 games while acknowledging the practical uncertainty ahead. It would also let the club adjust to the medical decision when it arrives, instead of requiring the most convenient possible outcome.

The next announcement will concern Jung’s hand. The roster discussion should remember what his bat already contributed: an .827 OPS, 27 doubles and an ability to reach base that Texas has reason to retain. Those are the baseball stakes behind the pending decision.

Sources

Dallas Morning News: offseason review

Dallas Morning News: medical updates

MLB: Rangers press conference

MLB: 2026 player statistics